UltraGreen.ai Limited manufactures and sells Indocyanine Green (ICG) pharmaceutical products in the United States and internationally. It provides diagnostic imaging analytics and software solutions. The company also develops software for real-time quantification of blood perfusion during surgery, including PerfusionWorks quantification software for tissue perfusion, lymphatic mapping, and margin assessment. In addition, it offers products, such as ICG, the IC-Flow Imaging System and the UltraGreen Data Platform and other technologies related to fluorescence guided surgery. Further, the company sells ICG vials and related pharmaceutical products; and engages in software development activities. It serves healthcare providers, hospitals, and medical technology companies. The company was formerly known as UltraGreen.ai Private Limited and changed its name to UltraGreen.ai Limited. UltraGreen.ai Limited was incorporated in 2024 and is based in Singapore. UltraGreen.ai Limited operates as a subsidiary of Renew Group Private Limited.
Research context
UltraGreen Ai Ltd appears in PyInvesting’s Singapore Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Healthcare
- Industry
- Health Information Services
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
No comments yet
Start a focused discussion about ULG.SG.